[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-357369-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-357369-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ginkgetin-enhances-the-antitumor-effect-of-taxol-on-human-breast-cancer-mcf-7-cells-via-ferroptosis-mediated-by-the-mdm2p53yap1-axis","Ginkgetin enhances the antitumor effect of Taxol on human breast cancer MCF-7 cells via ferroptosis mediated by the MDM2–p53–YAP1 axis","","Ginkgetin, a biflavone from Ginkgo biloba, is investigated for its ability to modulate ferroptosis in breast cancer and thereby potentiate Taxol therapy. The study shows ginkgetin induces ferroptosis in MCF-7 cells by elevating intracellular ROS and altering key ferroptosis regulators, including downregulation of GPX4, SLC7A11, SLC40A1 and glutathione, with concurrent changes in transferrin and ferroptosis markers. Ferrostatin-1 blocks these effects and partially reverses p53 nuclear translocation and YAP1 upregulation, indicating control through the MDM2–p53–YAP1 axis. In vivo xenografts, ginkgetin suppresses tumor growth and enhances Taxol’s antitumor effect synergistically.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ginkgetin-enhances-the-antitumor-effect-of-taxol-on-human-breast-cancer-mcf-7-cells-via-ferroptosis-mediated-by-the-mdm2p53yap1-axis/357369/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ginkgetin-enhances-the-antitumor-effect-of-taxol-on-human-breast-cancer-mcf-7-cells-via-ferroptosis-mediated-by-the-mdm2p53yap1-axis/357369.png","ImageObject",300,407,{"name":42,"@type":43},"Ben ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does ginkgetin affect ferroptosis in MCF-7 breast cancer cells?","Question",{"text":63,"@type":64},"Ginkgetin induces ferroptosis by increasing intracellular ROS accumulation and by downregulating ferroptosis-related factors such as GPX4, SLC7A11, and SLC40A1, along with glutathione expression while altering ferroptosis markers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role does ferrostatin-1 play in the study?",{"text":68,"@type":64},"Ferrostatin-1 inhibits ginkgetin-mediated ferroptosis and interferes with regulation of ferroptosis-related factors, partially reversing downstream pathway activation.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the MDM2–p53–YAP1 axis contribute to the combined effect with Taxol?",{"text":72,"@type":64},"Mechanistically, ginkgetin promotes p53 nuclear translocation and upregulates YAP1 by inhibiting MDM2’s suppressive effect on p53. This pathway activation supports enhanced Taxol pharmacological activity, and combined treatment shows synergistic antitumor effects in vivo.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},357369,1790154950,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nGinkgetin enhances the antitumor effect of Taxol on human breast cancer MCF-7 cells via ferroptosis mediated by the MDM2–p53–YAP1 axis  \nGuangchao Li1,2,5, Wen Yan3,5, Xiaoyun Peng2, Zhao Yin2 & Shaya Mahati4􀀍  \nGinkgetin, a biflavone isolated from Ginkgo biloba, is a potent Wnt signaling inhibitor that can enhance the pharmacological effects of cisplatin on non-small cell lung cancer (NSCLC) by activating the ferroptosis pathway. However, few studies have examined the role of ginkgetin in regulating ferroptosis in breast cancer cells. In this study, ginkgetin was found to induce ferroptosis by increasing intracellular reactive oxygen species (ROS) accumulation through the downregulation of GPX4, SLC7A11, SLC40A1, and glutathione expression along with the upregulation of transferrin, glutamate, cystine, and cell-free ferroptosis markers. Ferroptotic activity was inhibited using ferrostatin-1, which interfered with ginkgetin-mediated regulation offerroptosis-related factors, such as GPX4, SLC7A11, SLC40A1, and transferrin, and partially suppressed ginkgetin-induced activation of the ferroptosis pathway. Mechanistically, ginkgetin promoted p53 nuclear translocation and upregulated downstream YAP1 expression by inhibiting the suppressive effect of MDM2 on p53 in breast cancer cells, whereas ferrostatin-1 partially reversed these effects. Consequently, the pharmacological activity of Taxol in breast cancer cells was enhanced. Finally, using a cell line–derived xenograft (CDX) model, we found that ginkgetin induced ferroptosis and suppressed tumor growth, whereas the combined administration of Taxol and ginkgetin produced a synergistic antitumor effect in vivo. Overall,  \nthese findings indicate that ginkgetin enhances the tumor-suppressive effect of Taxol by activating ferroptosis through the MDM2–p53–YAP1 axis, suggesting a potential combination therapy for breast cancer treatment.  \nKeywords Ginkgetin, Ferroptosis, Luminal-subtype breast cancer, MDM2–p53–YAP1 axis, Ferrostatin-1, Taxol  \nBreast cancer is the most common malignant tumor among women worldwide, ranking first in incidence and surpassing lung cancer, while its mortality ranks fourth globally. Among women, it has the highest incidence among malignant tumors and remains a leading cause of cancer-related death1. Based on the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), breast cancer can be classified as hormone receptor–positive (HR+, i.e., ER+ and PR+) and HER2-negative (HER2− ), HER2-positive (HER2+), or triple-negative (ER − , PR − , and HER2− ) subtypes2. Based on immunohistochemical (IHC) analysis, breast cancer can be categorized into luminal A, luminal B, HER2 overexpression, and basal-like subtypes3. The MCF-7 cell line is one of the most commonly used luminal-subtype breast cancer models, which is characterized by elevated ER and PR expression and an overall favorable prognosis. Repeated drug treatment or intervention may lead to the development of resistance, resulting in stable drug-resistant cell lines that are widely used in breast cancer cell research4. When breast cancer progresses to an advanced stage—particularly  \n1College of Life Sciences and Technology, Jinan University, Guangzhou 510632, China. 2Department of Hematology, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou 510317, China.  \n3Department of Oncology, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou 510317, Guangdong, China. 4Department of Oncology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China. 5Guangchao Li and Wen Yan have contributed equally to this work as co-first author. 􀀍 email: [sasa870716@126.com](sasa870716@126.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nwhen cells become ","cbCaibcfHrhkBag0","https://ap.wps.com/l/cbCaibcfHrhkBag0","pdf",3574081,12,"English","# Introduction\n## Breast cancer classification and treatment challenges\n## Mechanisms of major therapies\n# Results\n## Ginkgetin induces ferroptosis in MCF-7 cells\n## Ferrostatin-1 inhibition and pathway validation\n## MDM2–p53–YAP1 axis involvement\n## Synergistic antitumor activity with Taxol in vivo\n# Discussion\n## Therapeutic implications for combination therapy","[{\"question\":\"How does ginkgetin affect ferroptosis in MCF-7 breast cancer cells?\",\"answer\":\"Ginkgetin induces ferroptosis by increasing intracellular ROS accumulation and by downregulating ferroptosis-related factors such as GPX4, SLC7A11, and SLC40A1, along with glutathione expression while altering ferroptosis markers.\"},{\"question\":\"What role does ferrostatin-1 play in the study?\",\"answer\":\"Ferrostatin-1 inhibits ginkgetin-mediated ferroptosis and interferes with regulation of ferroptosis-related factors, partially reversing downstream pathway activation.\"},{\"question\":\"How does the MDM2–p53–YAP1 axis contribute to the combined effect with Taxol?\",\"answer\":\"Mechanistically, ginkgetin promotes p53 nuclear translocation and upregulates YAP1 by inhibiting MDM2’s suppressive effect on p53. This pathway activation supports enhanced Taxol pharmacological activity, and combined treatment shows synergistic antitumor effects in vivo.\"}]","Ginkgetin enhances the antitumor effect of Taxol on human breast cancer MCF-7 cells via ferroptosis mediated by the MDM2–p53–YAP1 axis | PDF",1790129787,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7160ce1bee39c50543bf747b2e26558b.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16f8e19c1256e302ffe77bbd13a477e0.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14605770e6a5908fc6546f4ead3d7a34.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de4c81ff9c40e89e9ddc26e28a3b2a93.webp",980,1287]